| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.92B | +14.8% |
| Cost of Revenue | $3.59B | +13.5% |
| Gross Profit | $2.33B | +17.0% |
| R&D Expense | $91.0M | +23.0% |
| SG&A Expense | $1.10B | +6.6% |
| Operating Income | $817.3M | +44.5% |
| Interest Expense | $103.2M | +17.7% |
| Pre-tax Income | $742.2M | +44.7% |
| Income Tax | $149.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.61B | -23.5% |
| Accounts Receivable | $1.12B | +18.3% |
| Inventory | $1.03B | +20.0% |
| Current Assets | $3.97B | -3.6% |
| Total Assets | $14.77B | -2.6% |
| Current Liabilities | $1.67B | +14.1% |
| Long-term Debt | $2.72B | -2.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Financing Cash Flow | -$954.0M | +17.5% |
| +786.2% |
| Net Income | $604.7M | +7.5% |
| EPS (Basic) | $1.49 | +9.6% |
| EPS (Diluted) | $1.47 | +9.7% |
| Total Liabilities |
| $5.51B |
| -9.4% |
| Stockholders' Equity | $9.20B | +2.2% |